BIOMAT Database Logo BIOMAT Database Logo

Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production. 1997

R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Department of Physiology, Wayne State University School of Medicine, and VAMC, Detroit, MI, USA.

Insulin like growth factor 1 (IGF-1) vasodilates, increases blood flow and lowers blood pressure; nitric oxide (NO) has been suggested to mediate some of these effects. We studied the role of IGF-1 in the regulation of NO production in vascular smooth muscle cells (VSMC). IGF-1 induced a concentration and time-dependent increase in NO release from endothelium-denuded aortic rings. Pre-incubation with cycloheximide or aminoguanidine blocked IGF-1-stimulated NO release. In addition, a six-fold increase in NO production by VSMC was seen upon incubation with IGF-1. These results suggest that IGF-1 induces NO release in VSMC through a process that involves new protein synthesis and the inducible isoform of nitric oxide synthase.

UI MeSH Term Description Entries
D007334 Insulin-Like Growth Factor I A well-characterized basic peptide believed to be secreted by the liver and to circulate in the blood. It has growth-regulating, insulin-like, and mitogenic activities. This growth factor has a major, but not absolute, dependence on GROWTH HORMONE. It is believed to be mainly active in adults in contrast to INSULIN-LIKE GROWTH FACTOR II, which is a major fetal growth factor. IGF-I,Somatomedin C,IGF-1,IGF-I-SmC,Insulin Like Growth Factor I,Insulin-Like Somatomedin Peptide I,Insulin Like Somatomedin Peptide I
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009131 Muscle, Smooth, Vascular The nonstriated involuntary muscle tissue of blood vessels. Vascular Smooth Muscle,Muscle, Vascular Smooth,Muscles, Vascular Smooth,Smooth Muscle, Vascular,Smooth Muscles, Vascular,Vascular Smooth Muscles
D009569 Nitric Oxide A free radical gas produced endogenously by a variety of mammalian cells, synthesized from ARGININE by NITRIC OXIDE SYNTHASE. Nitric oxide is one of the ENDOTHELIUM-DEPENDENT RELAXING FACTORS released by the vascular endothelium and mediates VASODILATION. It also inhibits platelet aggregation, induces disaggregation of aggregated platelets, and inhibits platelet adhesion to the vascular endothelium. Nitric oxide activates cytosolic GUANYLATE CYCLASE and thus elevates intracellular levels of CYCLIC GMP. Endogenous Nitrate Vasodilator,Mononitrogen Monoxide,Nitric Oxide, Endothelium-Derived,Nitrogen Monoxide,Endothelium-Derived Nitric Oxide,Monoxide, Mononitrogen,Monoxide, Nitrogen,Nitrate Vasodilator, Endogenous,Nitric Oxide, Endothelium Derived,Oxide, Nitric,Vasodilator, Endogenous Nitrate
D011500 Protein Synthesis Inhibitors Compounds which inhibit the synthesis of proteins. They are usually ANTI-BACTERIAL AGENTS or toxins. Mechanism of the action of inhibition includes the interruption of peptide-chain elongation, the blocking the A site of ribosomes, the misreading of the genetic code or the prevention of the attachment of oligosaccharide side chains to glycoproteins. Protein Synthesis Antagonist,Protein Synthesis Antagonists,Protein Synthesis Inhibitor,Antagonist, Protein Synthesis,Antagonists, Protein Synthesis,Inhibitor, Protein Synthesis,Inhibitors, Protein Synthesis,Synthesis Antagonist, Protein,Synthesis Inhibitor, Protein
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D003513 Cycloheximide Antibiotic substance isolated from streptomycin-producing strains of Streptomyces griseus. It acts by inhibiting elongation during protein synthesis. Actidione,Cicloheximide
D004730 Endothelium, Vascular Single pavement layer of cells which line the luminal surface of the entire vascular system and regulate the transport of macromolecules and blood components. Capillary Endothelium,Vascular Endothelium,Capillary Endotheliums,Endothelium, Capillary,Endotheliums, Capillary,Endotheliums, Vascular,Vascular Endotheliums
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D006146 Guanidines A family of iminourea derivatives. The parent compound has been isolated from mushrooms, corn germ, rice hulls, mussels, earthworms, and turnip juice. Derivatives may have antiviral and antifungal properties.

Related Publications

R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Insulin-like growth factor I inhibits induction of nitric oxide synthase in vascular smooth muscle cells.
January 1994, Circulation research,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Fibroblast growth factor regulates insulin-like growth factor-binding protein production by vascular smooth muscle cells.
February 1994, The American journal of the medical sciences,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
[Effect of insulin and insulin-like growth factor-1 on vascular smooth muscle cells].
July 1997, Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Insulin-like growth factor binding protein production by bovine and human vascular smooth muscle cells: production of insulin-like growth factor binding protein-6 by human smooth muscle.
December 1996, Endocrinology,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Insulin and insulin-like growth factor-I promotes angiotensinogen production and growth in vascular smooth muscle cells.
August 2000, Journal of hypertension,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance.
October 2004, European journal of clinical investigation,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Tumor necrosis factor-alpha regulates insulin-like growth factor-1 and insulin-like growth factor binding protein-3 expression in vascular smooth muscle.
March 2002, Circulation,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Tranilast restores cytokine-induced nitric oxide production against platelet-derived growth factor in vascular smooth muscle cells.
August 1996, Journal of cardiovascular pharmacology,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Mechanical stretch augments insulin-induced vascular smooth muscle cell proliferation by insulin-like growth factor-1 receptor.
October 2011, Experimental cell research,
R Muniyappa, and M F Walsh, and J S Rangi, and R M Zayas, and P R Standley, and J L Ram, and J R Sowers
Monocyte-vascular smooth muscle cell interaction enhances nitric oxide production.
March 1998, Cardiovascular research,
Copied contents to your clipboard!